Search Results for: cynata

Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte

/ / 2 Comments
VC-01-post-implant-final1-e1503703572933, viacyte

It’s a difficult, but very important road to conclusively prove that an investigational stem cell therapy is both safe and effective in order to get final approval FDA or equivalents in other countries. For this reason, it is beneficial to highlight even small, but positive steps forward including encouraging pre-clinical data. Today I’m doing a […]

Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte Read More »

Cynata stem cell trial update: CEO Ross Macdonald interview

/ / 2 Comments
Koch-et-al_2016_MCA-derived-MSC-Treatment-of-Hindlimb-Ischemia-in-Mice-e1498668676851

Stem cell clinical trials have a certain gravitational pull for me as I’m always fascinated by them and since the new Cynata trial is moving forward, I recently did an interview their CEO, Dr. Ross A. Macdonald to find out more. PK: Cynata’s recently initiated clinical trial aims to treat GVHD as have other stem

Cynata stem cell trial update: CEO Ross Macdonald interview Read More »

Cynata approval for 1st ever allo trial of IPSC-derived MSCs for GVHD

/ / 6 Comments
Cynata

Cynata Therapeutics Limited has received approval from UK regulators to start a first-of-its-kind allogeneic IPSC-based trial of MSCs for graft versus host disease (GVHD). Cynata also had some big news a couple weeks back with a deal with Fujifilm. The company is aiming to recruit 16 patients to test whether the MSCs (a type of adult

Cynata approval for 1st ever allo trial of IPSC-derived MSCs for GVHD Read More »

Weekly reads: diabetes, GvHD, Novo Nordisk & regenerative medicine, HDACs

/ / 2 Comments
mesenchymal cells

Do many in the regenerative medicine field have favorite types of stem cells? Some seem to think there’s a tension between those working on pluripotent stem cells like iPS cells and those working with MSCs. I don’t see it that way, though. Whatever stem cells work best for a particular condition should be used and,

Weekly reads: diabetes, GvHD, Novo Nordisk & regenerative medicine, HDACs Read More »

24 cell therapy & stem cell stocks I’m following

/ / 5 Comments
stem cell stocks

Stem cell stocks, meaning cellular therapy biotech companies, face many challenges, but their clinical research is crucial. Stem cell biotechs These biotechs have ups and downs, sometimes at the same time. This is kind of the standard of “life” as any biotech company. It is definitely the case in the volatile stem cell and cell

24 cell therapy & stem cell stocks I’m following Read More »

What are induced pluripotent stem cells or IPS cells?

/ / 6 Comments
induced pluripotent stem cells clinical trials map

Induced pluripotent stem cells or iPS cells just might be the most exciting development in the stem cell field over the last 15 years. They have unique potential for clinical impact for regenerative medicine too. This may manifest both through their use to produce differentiated cellular therapies and indirectly via disease modeling as well as

What are induced pluripotent stem cells or IPS cells? Read More »

Overview of IPS cell prospects for clinical impact

/ / Leave a Comment
IPS-cell-clincial-trials-map

IPS cell research is a growing area of promise for regenerative medicine. These stem cells, also known as iPSCs or more formally as Induced Pluripotent Stem Cells, are engineered cells that are programmed to function the same way as embryonic stem cells. They can be differentiated into possibly any type of cell that is needed for

Overview of IPS cell prospects for clinical impact Read More »

Recommended reads: Yamanaka review, stem cell indictment, COVID, MYC, more

/ / 1 Comment
Paolo-Macchiarini

Here are some recommended stem cell and other reads for the week ranging from COVID developments to prosecutors finally catching up with a stem cell surgeon who had many patients die to a list of interesting pubs. Because Trump now has COVID, I wondered on Friday if he might consider trying unproven stem cells or

Recommended reads: Yamanaka review, stem cell indictment, COVID, MYC, more Read More »

Cell therapy trials for COVID-19 accelerate & some early reports

/ / 11 Comments
MultiStem-Athersys-cell-therapy-COVID-19

Could various kinds of cell therapy help patients with COVID-19? A variety of cell therapies, mostly focused on mesenchymal stromal/stem cells (MSCs), have gotten cleared quickly in the U.S., China, and Israel and possibly other countries to be tested in patients with the novel coronavirus. I hope at least one proves helpful. It’s mostly a

Cell therapy trials for COVID-19 accelerate & some early reports Read More »